Abstract
Methamphetamine (MA), a highly abused psychostimulant, exerts neurotoxic effects on the dopaminergic system via several neurotoxicity mechanisms in the long-term administration. Since the effect of MA on the signaling insulin pathway is less studied, the current study was designed to evaluate the effect of escalating an MA regimen on different insulin signaling elements in substantia nigra (SN) and striatum of a rat. Increasing MA doses (1-14 mg/kg) were administrated intraperitoneally twice a day for 14 days in rats. In the control group, normal saline was injected in the same volume. On days 1, 14, 28, and 60 after MA discontinuation, molecular assessments were performed. Insulin receptor (IR) and insulin receptor substrate (IRS) 1 and 2 gene expression were evaluated using real-time polymerase chain reaction, and protein levels of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K), phospho-PI3K, Akt, phospho-Akt, glycogen synthase kinase 3β (GSK3β), and phospho-GSK3β were measured by the Western blot analysis in SN and striatum. Messenger RNA levels of IR and insulin receptor substrate 2 were increased in SN, 1 day after the last injection. Although no changes were observed in PI3K, phospho-PI3K, Akt, phospho-Akt, and GSK...Continue Reading
References
Mar 7, 2001·The American Journal of Psychiatry·N D VolkowE N Miller
Jun 17, 2003·Molecular and Cellular Biology·Joseph F SanchezSanjay B Maggirwar
Jul 15, 2004·FEBS Letters·Hsingchi J LinWu Ma
Mar 20, 2008·Biochimica Et Biophysica Acta·Ana I DuarteA Cristina Rego
Mar 31, 2009·Brain Research Reviews·Irina N Krasnova, Jean Lud Cadet
Apr 17, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tetyana DukaAnita Sidhu
Jun 3, 2009·Archives of Physiology and Biochemistry·Zvi Laron
Nov 17, 2009·PloS One·Jean Lud CadetAmber B Hodges
Apr 2, 2011·Neuroscience·A A BraunM T Williams
Apr 19, 2011·Journal of Molecular Endocrinology·Kenneth Siddle
Apr 27, 2011·Journal of Neurochemistry·Chun-Mei XuLin Lu
Jun 7, 2011·Neuroscience·B A MorrowJ D Elsworth
Sep 9, 2011·Psychopharmacology·Jun WangJie Shi
Oct 5, 2011·PloS One·Nicole SpeedAurelio Galli
Oct 25, 2011·PloS One·Amina El Ayadi, Michael J Zigmond
Apr 14, 2012·Journal of Aging Research·Ana I DuarteCatarina R Oliveira
Jun 1, 2012·Behavioural Brain Research·Nicole M Enman, Ellen M Unterwald
Jun 20, 2012·Trends in Neurosciences·John F Marshall, Steven J O'Dell
Jul 24, 2012·Pharmacology & Therapeutics·William A BanksMichelle A Erickson
Dec 13, 2012·Current Diabetes Reviews·Fatemeh Derakhshan, Cory Toth
Feb 21, 2013·ACS Chemical Neuroscience·J A Morales-GarcíaA Pérez-Castillo
Apr 23, 2013·Journal of Internal Medicine·S Ares-SantosR Moratalla
Jan 17, 2014·Molecular Neurobiology·Eun-Joo ShinHyoung-Chun Kim
Jun 4, 2014·The European Journal of Neuroscience·Sharanya M KousikT Celeste Napier
Jul 6, 2014·Acta Pharmacologica Sinica·Xiao-Min ZhangMin-Hua Zhang
Jul 16, 2014·PloS One·James P O'CallaghanDiane B Miller
Aug 15, 2014·Cell Death & Disease·R XuG Wang
Jan 8, 2015·Frontiers in Behavioral Neuroscience·Stephen H BrarenPeter A Serrano
Mar 10, 2015·ACS Chemical Neuroscience·Kelly M LohrGary W Miller
Aug 15, 2015·Biochemical and Biophysical Research Communications·Jintao WuJinhao Sun
Jan 6, 2016·Brain Research·Dianne P Figlewicz
Apr 6, 2016·PloS One·Limin ZhangPingyi Xu
Nov 20, 2016·Journal of Cellular Biochemistry·Neda ValianLeila Dargahi
Apr 10, 2017·Neuronal Signaling·Julia A Callender, Alexandra C Newton